Pfizer's Zoeti (ZTS) IPO Prices at $26, Above Expected Range
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Zoetis (ZTS) Prices 86.1M IPO at $26/Share, Above Expected Range
February 1, 2013 6:53 AM ESTZoetis (NYSE: ZTS), formerly the animal health business unit of Pfizer Inc. (NYSE: PFE, announced the pricing of its initial public offering of 86,100,000 shares of its Class A common stock at $26 per share. The shares are expected to begin trading tomorrow, Feb. 1, on the New York Stock Exchange under the symbol... More
Pfizer's Zoetis (ZTS) May be Largest IPO Since Facebook (FB)
January 31, 2013 9:48 AM ESTEyes are on focus for the biggest IPO to hit the U.S. since Facebook(Nasdaq: FB).
Bloomberg notes today that Pfizer's animal health spin-off, Zoetis, Inc. (NYSE: ZTS), will unload 86.1 million shares today with an... More
